Zimmer Biomet Holdings Inc [ZBH] stock prices are up 7.99% to $98.43 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ZBH shares have gain 7.40% over the last week, with a monthly amount glided 3.39%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zimmer Biomet Holdings Inc [NYSE: ZBH] stock has seen the most recent analyst activity on July 15, 2025, when Roth Capital upgraded its rating to a Buy but kept the price target unchanged to $135 for it. Previously, JP Morgan upgraded its rating to Overweight on December 17, 2024, and elevated its price target to $128. On September 10, 2024, Wolfe Research initiated with a Peer Perform rating. Piper Sandler downgraded its rating to a Neutral and decreased its price target to $115 on July 01, 2024. Goldman initiated its recommendation with a Neutral and recommended $129 as its price target on May 30, 2024. Argus upgraded its rating to Buy for this stock on May 21, 2024, but kept the price target unchanged to $150. In a note dated January 04, 2024, Evercore ISI downgraded an In-line rating on this stock and revised its target price from $135 to $125.
The stock price of Zimmer Biomet Holdings Inc [ZBH] has been fluctuating between $89.22 and $116.71 over the past year. Currently, Wall Street analysts expect the stock to reach $106.5 within the next 12 months. Zimmer Biomet Holdings Inc [NYSE: ZBH] shares were valued at $98.43 at the most recent close of the market. An investor can expect a potential return of 8.2% based on the average ZBH price forecast.
Analyzing the ZBH fundamentals
The Zimmer Biomet Holdings Inc [NYSE:ZBH] reported sales of 7.70B for trailing twelve months, representing a surge of 6.97%. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.05 and Total Capital is 0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Zimmer Biomet Holdings Inc [NYSE:ZBH]’s Current Ratio is 2.44. Also, the Quick Ratio is 1.46, while the Cash Ratio stands at 0.3. Considering the valuation of this stock, the price to sales ratio is 2.53, the price to book ratio is 1.57 and price to earnings (TTM) ratio is 21.81.
Transactions by insiders
Recent insider trading involved Yi Sang, Group President, Asia Pacific, that happened on Jun 13 ’25 when 800.0 shares were sold. Group President, Asia Pacific, Yi Sang completed a deal on Jun 11 ’25 to sell 1000.0 shares. Meanwhile, Officer Yi Sang bought 800.0 shares on Jun 13 ’25.
